Description
SWOT ANALYSIS OF ESSILOR INTERNATIONAL
Essilor International
Parent Company
Essilor International S A
Category
Healthcare
Sector
Medical equipment
Tagline/ Slogan
Seeing the world better
design to manufacture, the group develops a wide range of lenses to USP correct and protect eyesight
STP
Segment
Healthcare
Target Group
Prescription laboratories and Optical professionals
To allow as many people as possible to see well to improve their quality Positioning of life
SWOT Analysis
1. Responsible for creating Varilux, the world's first progressive lens which corrects presbyopia and allows clear vision in the wearer's near, intermediate and far vision 2. Operates in over 100 countries over five continents 3. One of the world's largest manufacturer of ophthalmic lenses, dominating the market on every continent 4. Leader in North America through acquisition of FGX International Strength 5. Strong brand reputation and presence across the world
1. Activities are largely focused on research and development – Scope for concentration on sales and mareting and improving brand equity Weakness 2.Limited presence in emerging markets
1. Innovation at all levels - products, services and marketing 2. conquer the middle of the range, in developed countries, 3. pursuing a policy of acquisitions and partnerships with prescription laboratories and distributors 4. conduct initiatives at a very early stage in the value chain to offer information, check-ups and supply lenses, in regions of the world where Opportunity access to optical care is difficult.
1.Narrow portfolio of products – Can diversify to mitigate risks 2.Government regulations and industry stagnation Threats 3.Competitive industry with focus on technology
Competition
1.Bausch & lomb incorporated 2.Carl Zeiss AG Competitors 3.Hoya Corporation
doc_746080078.docx
SWOT ANALYSIS OF ESSILOR INTERNATIONAL
Essilor International
Parent Company
Essilor International S A
Category
Healthcare
Sector
Medical equipment
Tagline/ Slogan
Seeing the world better
design to manufacture, the group develops a wide range of lenses to USP correct and protect eyesight
STP
Segment
Healthcare
Target Group
Prescription laboratories and Optical professionals
To allow as many people as possible to see well to improve their quality Positioning of life
SWOT Analysis
1. Responsible for creating Varilux, the world's first progressive lens which corrects presbyopia and allows clear vision in the wearer's near, intermediate and far vision 2. Operates in over 100 countries over five continents 3. One of the world's largest manufacturer of ophthalmic lenses, dominating the market on every continent 4. Leader in North America through acquisition of FGX International Strength 5. Strong brand reputation and presence across the world
1. Activities are largely focused on research and development – Scope for concentration on sales and mareting and improving brand equity Weakness 2.Limited presence in emerging markets
1. Innovation at all levels - products, services and marketing 2. conquer the middle of the range, in developed countries, 3. pursuing a policy of acquisitions and partnerships with prescription laboratories and distributors 4. conduct initiatives at a very early stage in the value chain to offer information, check-ups and supply lenses, in regions of the world where Opportunity access to optical care is difficult.
1.Narrow portfolio of products – Can diversify to mitigate risks 2.Government regulations and industry stagnation Threats 3.Competitive industry with focus on technology
Competition
1.Bausch & lomb incorporated 2.Carl Zeiss AG Competitors 3.Hoya Corporation
doc_746080078.docx